H.R. 4396

[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 4396 Introduced in House (IH)] <DOC> 119th CONGRESS 1st Session H. R. 4396 To direct the Secretary of Health and Human Services to study and report on the relationship between hair straighteners and uterine cancer, particularly among women of color. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES July 15, 2025 Ms. Clarke of New York (for herself, Ms. Brown, Mrs. Watson Coleman, Ms. Kelly of Illinois, Mr. David Scott of Georgia, Ms. Norton, Ms. Sewell, Mrs. Foushee, Ms. McClellan, Ms. Velazquez, Mr. Fields, Mrs. Dingell, Ms. Tlaib, Mrs. Trahan, Mr. Johnson of Georgia, Ms. Ansari, Mr. Thanedar, Mr. Thompson of Mississippi, Mr. Krishnamoorthi, Ms. Salinas, Mrs. McIver, Mr. Carter of Louisiana, Ms. Wilson of Florida, Ms. Lee of Pennsylvania, Ms. Wasserman Schultz, Mr. Figures, Ms. Adams, Mr. Khanna, Mr. Meeks, Mr. Green of Texas, Ms. Tokuda, Ms. Rivas, and Mr. Mannion) introduced the following bill; which was referred to the Committee on Energy and Commerce _______________________________________________________________________ A BILL To direct the Secretary of Health and Human Services to study and report on the relationship between hair straighteners and uterine cancer, particularly among women of color. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Uterine Cancer Study Act of 2025''. SEC. 2. STUDY ON RELATIONSHIP BETWEEN HAIR STRAIGHTENERS AND UTERINE CANCER. (a) Study.--The Secretary of Health and Human Services, in coordination with the Commissioner of Food and Drugs and the Director of the National Institutes of Health, shall conduct a study on the relationship between hair straighteners and uterine cancer, with a focus on the increased incidence of such cancer among women of color. Such study shall-- (1) review significant findings and recommendations from other studies regarding the relationship between hair straighteners and uterine cancer; (2) consider impacts on women and other individuals at risk of uterine cancer from all racial and ethnic backgrounds; (3) disaggregate the results of the study under this section according to whether the hair straighteners contain dyes or coloring, bleach, highlights, or perms; and (4) determine whether the Food and Drug Administration should impose additional testing requirements on the manufacturers of hair straightening products to ensure the safety of such products. (b) Methodology.--Not later than 45 days after the date of enactment of this Act, the Secretary shall submit to the Committee on Energy and Commerce of the House of Representatives and the Committee on Health, Education, Labor, and Pensions of the Senate a description of the methodology that will be used to conduct the study under this section. (c) Commencement.--Not later than 180 days after the date of enactment of this Act, the Secretary shall commence the study under this section. (d) Report.--Not later than 2 years after the date of enactment of this Act, the Secretary shall complete the study under this section and submit to the Committee on Energy and Commerce of the House of Representatives and the Committee on Health, Education, Labor, and Pensions of the Senate a report on the results of such study. (e) Definition.--In this section: (1) The term ``hair straightener'' means a chemical hair straightener. (2) The term ``Secretary'' means the Secretary of Health and Human Services. <all>